Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

May 08, 2025 12:00 PM - May 08, 2025 1:00 PM

(US Eastern Standard Time)

Rethinking Evidence: Leveraging Real-World Data to Accelerate Drug Development hosted by OM1

Join us to see how RWD, AI, and automation are reshaping observational studies—delivering faster insights, less burden, and regulatory-ready evidence.

Presenters

Nancy  Dreyer, MPH, FISPE

Nancy Dreyer, MPH, FISPE

Founder, Dreyer Strategies LLC, United States

Nancy Dreyer brings her experience as Chief Scientific Officer at IQVIA Real World Solutions and SVP roles at IQVIA, Quintiles, Outcome Sciences Inc and UnitedHealth Group to independent consultancy. Her work focuses on advancing the use of real-world evidence for safety, effectiveness and natural history research, using diverse forms of data including patient-generated health data, electronic medical records, medical and pharmacy claims, data linkage and data integration. She is a Fellow of International Society of Pharmacoepidemiology (ISPE) and of DIA, and is a Science and Policy Advisor to DIA, Adjunct Professor of Epidemiology at the Univ of North Carolina at Chapel Hill and a member of ISPOR's RWE Leadership Team.

Eric  Schrock

Eric Schrock

Chief Technology Officer, OM1, United States

Eric Schrock is Chief Technology Officer and Head of Evidence Generation Solutions at OM1, where he leads a diverse technology team spanning product engineering, data engineering, product management, information security, and IT. He is responsible for shaping and driving OM1's digital strategy and overseeing product development in areas such as data analytics, patient and site experience, and AI-powered personalized medicine. Before joining OM1, Eric was the CTO at Jvion, where he managed teams across product delivery, engineering, professional services, and customer success.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.